MedPath

Cyclizine

Generic Name
Cyclizine
Drug Type
Small Molecule
Chemical Formula
C18H22N2
CAS Number
82-92-8
Unique Ingredient Identifier
QRW9FCR9P2

Overview

A histamine H1 antagonist given by mouth or parenterally for the control of postoperative and drug-induced vomiting and in motion sickness. (From Martindale, The Extra Pharmacopoeia, 30th ed, p935)

Background

A histamine H1 antagonist given by mouth or parenterally for the control of postoperative and drug-induced vomiting and in motion sickness. (From Martindale, The Extra Pharmacopoeia, 30th ed, p935)

Indication

For prevention and treatment of nausea, vomiting, and dizziness associated with motion sickness, and vertigo (dizziness caused by other medical problems).

Associated Conditions

  • Migraine
  • Motion Sickness

Clinical Trials

Title
Posted
Study ID
Phase
Status
Sponsor

No clinical trials found

No clinical trials found for this drug

FDA Approved Products

Product Name
Manufacturer
Route
Strength
Approved
NDC Code

No FDA products found

No FDA products found for this drug

EMA Approved Products

Medicine Name
EMA Number
Auth. Holder
Country
Drug Type
Status
Issued
Opinion
Revision

No EMA products found

No EMA products found for this drug

HSA Approved Products

Product Name
Manufacturer
Dosage Form
Strength
Approved
Approval No.
TABLET
50mg
2017/10/23
SIN15353P
TABLET
50mg
2017/03/20
SIN15193P

NMPA Approved Products

Product Name
Approval No.
Manufacturer
Dosage Form
Trade Name
Strength
Type
Status
Date
Import
国药准字H44025111
胶囊剂
N/A
25mg
Chemical Drug
Approved
2021/01/12
Domestic
国药准字H44025110
N/A
N/A
25mg
Chemical Drug
Approved
2003/05/31
Domestic

PPB Approved Products

Product Name
Registration Code
Company
Category
Sale Type
Reg. Date

No PPB products found

No PPB products found for this drug

TGA Approved Products

Product Name
ARTG ID
Sponsor
Status
Reg. Date
Ingredient
231174
Active
2014/11/28
cyclizine hydrochloride
© Copyright 2025. All Rights Reserved by MedPath